vs
Digimarc CORP（DMRC）与Sunshine Biopharma Inc.（SBFM）财务数据对比。点击上方公司名可切换其他公司
Digimarc CORP的季度营收约是Sunshine Biopharma Inc.的1.0倍（$8.9M vs $8.6M），Sunshine Biopharma Inc.净利率更高（-25.0% vs -47.2%，领先22.3%），Digimarc CORP同比增速更快（2.9% vs -10.6%），Digimarc CORP自由现金流更多（$895.0K vs $-1.6M），过去两年Sunshine Biopharma Inc.的营收复合增速更高（6.6% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
阳光生物制药是一家临床阶段生物制药企业，专注于肿瘤、神经退行性疾病及感染性疾病创新疗法的研发与商业化，布局全球市场，推进靶向治疗候选药物管线，致力于满足未被满足的临床需求。
DMRC vs SBFM — 直观对比
营收规模更大
DMRC
是对方的1.0倍
$8.6M
营收增速更快
DMRC
高出13.5%
-10.6%
净利率更高
SBFM
高出22.3%
-47.2%
自由现金流更多
DMRC
多$2.5M
$-1.6M
两年增速更快
SBFM
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $8.6M |
| 净利润 | $-4.2M | $-2.1M |
| 毛利率 | 63.5% | 35.3% |
| 营业利润率 | -48.2% | -20.9% |
| 净利率 | -47.2% | -25.0% |
| 营收同比 | 2.9% | -10.6% |
| 净利润同比 | 51.4% | 0.8% |
| 每股收益（稀释后） | $-0.18 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCSBFM
| Q4 25 | $8.9M | $8.6M | ||
| Q3 25 | $7.6M | $9.4M | ||
| Q2 25 | $8.0M | $9.4M | ||
| Q1 25 | $9.4M | $8.9M | ||
| Q4 24 | $8.7M | $9.6M | ||
| Q3 24 | $9.4M | $8.4M | ||
| Q2 24 | $10.4M | $9.3M | ||
| Q1 24 | $9.9M | $7.5M |
净利润DMRCSBFM
| Q4 25 | $-4.2M | $-2.1M | ||
| Q3 25 | $-8.2M | $-883.8K | ||
| Q2 25 | $-8.2M | $-1.8M | ||
| Q1 25 | $-11.7M | $-1.2M | ||
| Q4 24 | $-8.6M | $-2.2M | ||
| Q3 24 | $-10.8M | $-1.2M | ||
| Q2 24 | $-9.3M | $-494.3K | ||
| Q1 24 | $-10.3M | $-1.3M |
毛利率DMRCSBFM
| Q4 25 | 63.5% | 35.3% | ||
| Q3 25 | 58.3% | 32.6% | ||
| Q2 25 | 58.8% | 36.4% | ||
| Q1 25 | 65.0% | 30.7% | ||
| Q4 24 | 60.8% | 32.2% | ||
| Q3 24 | 62.4% | 34.0% | ||
| Q2 24 | 66.1% | 25.3% | ||
| Q1 24 | 62.5% | 31.2% |
营业利润率DMRCSBFM
| Q4 25 | -48.2% | -20.9% | ||
| Q3 25 | -109.7% | -11.5% | ||
| Q2 25 | -105.2% | -21.8% | ||
| Q1 25 | -128.9% | -14.6% | ||
| Q4 24 | -105.1% | -21.7% | ||
| Q3 24 | -120.4% | -13.1% | ||
| Q2 24 | -96.2% | -13.6% | ||
| Q1 24 | -109.2% | -17.9% |
净利率DMRCSBFM
| Q4 25 | -47.2% | -25.0% | ||
| Q3 25 | -106.9% | -9.4% | ||
| Q2 25 | -102.6% | -18.8% | ||
| Q1 25 | -125.2% | -13.3% | ||
| Q4 24 | -99.9% | -22.5% | ||
| Q3 24 | -113.9% | -14.2% | ||
| Q2 24 | -89.3% | -5.3% | ||
| Q1 24 | -104.0% | -17.0% |
每股收益（稀释后）DMRCSBFM
| Q4 25 | $-0.18 | — | ||
| Q3 25 | $-0.38 | $-0.54 | ||
| Q2 25 | $-0.38 | $-0.82 | ||
| Q1 25 | $-0.55 | $-0.44 | ||
| Q4 24 | $-0.40 | $49.77 | ||
| Q3 24 | $-0.50 | $-11.61 | ||
| Q2 24 | $-0.43 | $-43.48 | ||
| Q1 24 | $-0.50 | $-2.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $23.0M |
| 总资产 | $53.0M | $30.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DMRCSBFM
| Q4 25 | $12.9M | — | ||
| Q3 25 | $12.6M | — | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $21.6M | — | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $33.7M | — | ||
| Q2 24 | $41.5M | — | ||
| Q1 24 | $48.9M | — |
股东权益DMRCSBFM
| Q4 25 | $40.2M | $23.0M | ||
| Q3 25 | $41.4M | $24.2M | ||
| Q2 25 | $46.5M | $25.7M | ||
| Q1 25 | $50.0M | $22.7M | ||
| Q4 24 | $61.4M | $23.5M | ||
| Q3 24 | $70.2M | $25.0M | ||
| Q2 24 | $77.2M | $23.5M | ||
| Q1 24 | $84.5M | $24.8M |
总资产DMRCSBFM
| Q4 25 | $53.0M | $30.1M | ||
| Q3 25 | $55.4M | $31.5M | ||
| Q2 25 | $60.7M | $32.0M | ||
| Q1 25 | $66.5M | $29.2M | ||
| Q4 24 | $75.8M | $30.6M | ||
| Q3 24 | $85.0M | $30.1M | ||
| Q2 24 | $93.4M | $29.3M | ||
| Q1 24 | $99.7M | $31.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-1.6M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-1.6M |
| 自由现金流率自由现金流/营收 | 10.0% | -18.9% |
| 资本支出强度资本支出/营收 | 1.1% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $-5.5M |
8季度趋势，按日历期对齐
经营现金流DMRCSBFM
| Q4 25 | $991.0K | $-1.6M | ||
| Q3 25 | $-2.6M | $-727.8K | ||
| Q2 25 | $-4.7M | $-1.3M | ||
| Q1 25 | $-5.5M | $-1.7M | ||
| Q4 24 | $-4.2M | $-3.4M | ||
| Q3 24 | $-7.1M | $-1.4M | ||
| Q2 24 | $-6.8M | $-4.6M | ||
| Q1 24 | $-8.4M | $-3.2M |
自由现金流DMRCSBFM
| Q4 25 | $895.0K | $-1.6M | ||
| Q3 25 | $-2.8M | $-735.8K | ||
| Q2 25 | $-4.9M | $-1.4M | ||
| Q1 25 | $-5.5M | $-1.7M | ||
| Q4 24 | $-4.2M | $-3.5M | ||
| Q3 24 | $-7.2M | $-1.9M | ||
| Q2 24 | $-6.9M | $-5.6M | ||
| Q1 24 | $-8.5M | $-3.2M |
自由现金流率DMRCSBFM
| Q4 25 | 10.0% | -18.9% | ||
| Q3 25 | -36.9% | -7.8% | ||
| Q2 25 | -61.0% | -15.2% | ||
| Q1 25 | -59.1% | -19.3% | ||
| Q4 24 | -49.1% | -36.6% | ||
| Q3 24 | -75.7% | -22.2% | ||
| Q2 24 | -66.1% | -59.7% | ||
| Q1 24 | -85.8% | -43.1% |
资本支出强度DMRCSBFM
| Q4 25 | 1.1% | 0.0% | ||
| Q3 25 | 2.9% | 0.1% | ||
| Q2 25 | 2.5% | 1.7% | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 0.2% | 1.1% | ||
| Q3 24 | 0.7% | 6.1% | ||
| Q2 24 | 0.3% | 10.5% | ||
| Q1 24 | 1.1% | 0.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
SBFM
暂无分部数据
